Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa
Open Access
- 1 February 2024
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 38, 101060
Abstract
No abstract availableKeywords
Funding Information
- BioMarin Pharmaceutical Inc
This publication has 37 references indexed in Scilit:
- An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patientsClinical Genetics, 2009
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009
- Neuronal ceroid lipofuscinosesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in NewfoundlandClinical Genetics, 2008
- Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis by CNS Administration of a Serotype 2 Adeno-Associated Virus Expressing CLN2 cDNAHuman Gene Therapy, 2008
- Atypical CLN2 with later onset and prolonged course: a neuropathologic study showing different sensitivity of neuronal subpopulations to TPP1 deficiencyActa Neuropathologica, 2008
- CLN2/TPP1 deficiency: The novel mutation IVS7-10A>G causes intron retention and is associated with a mild disease phenotypeMolecular Genetics and Metabolism, 2008
- Neurological deterioration in late infantile neuronal ceroid lipofuscinosisNeurology, 2007
- Diagnosis of the neuronal ceroid lipofuscinoses: An updateBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Late infantile neuronal ceroid lipofuscinosis: Quantitative description of the clinical course in patients with CLN2 mutationsAmerican Journal of Medical Genetics, 2002